Results 141 to 150 of about 15,914 (251)

Pretargeted Radioimmunotherapy for B-Cell Lymphomas [PDF]

, 2007
Damian J. Green, John M. Pagel, Anastasia Pantelias, Nathan Hedin, Yukang Lin, D. Scott Wilbur, Ajay K. Gopal, Donald K. Hamlin, Oliver W. Press   +8 more
openalex   +1 more source

Feasibility of 186 Re-radioimmunotherapy for treatment in an adjuvant setting of colon cancer

, 2003
Seigo Kinuya, Kunihiko Yokoyama, Mishiroku IZUMO, Takami Sorita, Takashi Obata, Hirofumi Mori, Kazuhiro Shiba, Naoto Watanabe, Noriyuki Shuke, Takatoshi Michigishi, Norihisa Tonami   +10 more
openalex   +2 more sources

cGAS/STING-mediated γδ T cell recruitment drives radioresistance: implications for improving radioimmunotherapy outcomes. [PDF]

J Clin Invest
Braman BC, Raleigh DR.
europepmc   +1 more source

COX-2 inhibition synergizes with radioimmunotherapy by promoting TCF1⁺CD8⁺ T cell infiltration in NSCLC. [PDF]

Cancer Biol Med
Ma L, Bai M, Wang Y, Zhai X, Yu J, Meng X.   +5 more
europepmc   +1 more source

124I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of 131I-L19-SIP radioimmunotherapy [PDF]

, 2009
Bernard M. Tijink, Lars R. Perk, Marianne Budde, Marijke Stigter‐van Walsum, Gerard W.M. Visser, Reina W. Kloet, Ludger M. Dinkelborg, C. René Leemans, Dario Neri, Guus A.M.S. van Dongen   +9 more
openalex   +1 more source

Diselenide-bridged hybrid mesoporous silica for radiosensitization and radioprotection in the radioimmunotherapy of colorectal cancer. [PDF]

J Nanobiotechnology
Zhang F, Xie X, Lu J, Fang H, Ning Q, Wang J, Shan Y, Wang S, Zhao X, Chen F, Dong W, Chang Z, Li L.   +12 more
europepmc   +1 more source

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges

Frontiers in Oncology, 2020
Udo S. Gaipl, Gabriele Multhoff, A. Graham Pockley, Franz Rödel   +3 more
doaj   +1 more source

Development of dosimetric approaches to treatment planning for radioimmunotherapy. DOE annual report

, 1998
California Univ., Davis, CA (United States)
openalex   +2 more sources

Radioimmunotherapy with 131I-Rituximab in a Patient with Diffuse Large B-Cell Lymphoma Relapsed After Treatment with 90Y-Ibritumomab Tiuxetan [PDF]

, 2013
Geon Kang, Hye Jin Kang, Dong‐Yeop Shin, Ha Ra Gu, Hong Seok Choi, Sang Moo Lim   +5 more
openalex   +1 more source

DLL3-targeted immunoPET and radioimmunotherapy ligands. [PDF]

Am J Nucl Med Mol Imaging
Liang SH.
europepmc   +1 more source